Thirty-Day Outcomes From Standalone Minimally Invasive Surgery-Transforaminal Lumbar Interbody Fusion Patients in an Ambulatory Surgery Center vs. Hospital Setting

por Schlesinger, Scott, Krugman, Kimberly, Abbott, Diana, Arle, Jeffrey
Publicado 2020

Evaluation and associated risk factors for neutropenia with venetoclax and obinutuzumab in the treatment of chronic lymphocytic leukemia

por Samuels, Courtney, Abbott, Diana, Niemiec, Sierra, Tobin, Jennifer, Falco, Angela, Halsema, Keri, Kamdar, Manali
Publicado 2021

Hepatocyte growth factor and myopia: Genetic association analyses in a caucasian population

por Yanovitch, Tammy, Li, Yi-Ju, Metlapally, Ravikanth, Abbott, Diana, Viet, Khanh-Nhat Tran, Young, Terri L.
Publicado 2009

Incidence of Invasive Fungal Infections in Patients With Previously Untreated Acute Myeloid Leukemia Receiving Venetoclax and Azacitidine

por Zhang, Alexander, Johnson, Tanner, Abbott, Diana, Phupitakphol, Tanit, Gutman, Jonathan A, Pollyea, Daniel A, Koullias, Yiannis
Publicado 2022

Quantitative trait locus linkage analysis in a large Amish pedigree identifies novel candidate loci for erythrocyte traits

por Hinckley, Jesse D, Abbott, Diana, Burns, Trudy L, Heiman, Meadow, Shapiro, Amy D, Wang, Kai, Di Paola, Jorge
Publicado 2013

The contribution of the rs55705857 G allele to familial cancer risk as estimated in the Utah population database

por Hummel, Sarah, Kohlmann, Wendy, Kollmeyer, Thomas M., Jenkins, Robert, Sonnen, Joshua, Palmer, Cheryl A., Colman, Howard, Abbott, Diana, Cannon-Albright, Lisa, Cohen, Adam L.
Publicado 2019

Survival impact of pre-treatment neutrophils on oropharyngeal and laryngeal cancer patients undergoing definitive radiotherapy

por Sumner, Whitney A., Stokes, William A., Oweida, Ayman, Berggren, Kiersten L., McDermott, Jessica D., Raben, David, Abbott, Diana, Jones, Bernard, Gan, Gregory, Karam, Sana D.
Publicado 2017

An international collaborative family-based whole genome quantitative trait linkage scan for myopic refractive error

por Abbott, Diana, Li, Yi-Ju, Guggenheim, Jeremy A., Metlapally, Ravikanth, Malecaze, Francois, Calvas, Patrick, Rosenberg, Thomas, Paget, Sandrine, Zayats, Tetyana, Mackey, David A., Feng, Sheng, Young, Terri L.
Publicado 2012

Increased risk for other cancers in individuals with Ewing sarcoma and their relatives

por Abbott, Diana, O'Brien, Schuyler, Farnham, James M., Young, Erin L., Yap, Jeffrey, Jones, Kevin, Lessnick, Stephen L., Randall, R. Lor, Schiffman, Joshua D., Cannon‐Albright, Lisa A.
Publicado 2019

CD38 antibody re-treatment in daratumumab-refractory multiple myeloma after time on other therapies

por Perez de Acha, Olivia, Reiman, Lauren, Jayabalan, David S., Walker, Zachary J., Bosma, Grace, Keller, Alana L., Parzych, Sarah E., Abbott, Diana, Idler, Beau M., Ribadeneyra, Drew, Niesvizky, Ruben, Forsberg, Peter A., Mark, Tomer M., Sherbenou, Daniel W.
Publicado 2023

Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia

por Cherry, Evan M., Abbott, Diana, Amaya, Maria, McMahon, Christine, Schwartz, Marc, Rosser, Julie, Sato, Audrey, Schowinsky, Jeffrey, Inguva, Anagha, Minhajuddin, Mohd, Pei, Shanshan, Stevens, Brett, Winters, Amanda, Jordan, Craig T., Smith, Clayton, Gutman, Jonathan A., Pollyea, Daniel A.
Publicado 2021

Higher-dose venetoclax with measurable residual disease-guided azacitidine discontinuation in newly diagnosed acute myeloid leukemia

por Gutman, Jonathan A., Winters, Amanda, Kent, Andrew, Amaya, Maria, McMahon, Christine, Smith, Clayton, Jordan, Craig T., Stevens, Brett, Minhajuddin, Mohammad, Pei, Shanshan, Schowinsky, Jeffrey, Tobin, Jennifer, O’Brien, Kelly, Falco, Angela, Taylor, Elizabeth, Brecl, Constance, Zhou, Katie, Ho, Phuong, Sohalski, Connor, Dell-Martin, Jessica, Ondracek, Olivia, Abbott, Diana, Pollyea, Daniel A.
Publicado 2023